Human brain tissue with MOGHE carrying somatic SLC35A2 variants reveal aberrant protein expression and protein loss in the white matter
Acta Neuropathologica · 05.03.2025 · 149 (1)
DOI: 10.1007/s00401-025-02858-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neuropathologica, online erschienen am 05.03.2025. Verfasst von Erica Cecchini und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropathology, Partner of the European Reference Network (ERN) EpiCARE, Universitätsklinikum Erlangen, Friedrich-Alexander Universität…. Hauptthemen laut MEDLINE: White Matter, Brain, Monosaccharide Transport Proteins, Oligodendroglia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, Deutsche Forschungsgemeinschaft, Universitätsklinikum Erlangen.
Abstract (Originalsprache)
Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE) is a recently described disease entity primarily affecting young children with drug-resistant epilepsy, mainly affecting the frontal lobe. The condition is histopathologically defined by focal lesions with patchy areas of increased oligodendroglial cell density at the grey-white matter boundary and heterotopic neurons in the white matter. Approximately half of the individuals with MOGHE carry brain somatic variants in the SLC35A2 gene, which affects the UDP-galactose transporter and thus sphingolipid glycosylation. To investigate the impact of SLC35A2 variants on protein expression, we analysed MOGHE brain tissue with and without SLC35A2 mosaicism, distinguishing missense from nonsense variants. We developed an antibody targeting the N-terminus of the SLC35A2 galactose transporter and applied it for immunofluorescence (IF) analyses in a MOGHE cohort comprising 59 genetically tested individuals selected from three centres in Germany. The cohort included 13 individuals with SLC35A2 missense variants and 15 with SLC35A2 nonsense variants. Our findings confirm the localisation of the SLC35A2 protein in the Golgi apparatus of all neuroepithelial cell types as well as within Golgi outposts along oligodendroglial processes. The protein distribution was altered in MOGHE samples dependent on the SLC35A2 variant and its allelic frequency. Western blot and IF analyses revealed a significant SLC35A2 reduction in MOGHE tissues carrying nonsense variants. Ultrastructural analyses from three MOGHE samples demonstrated hypomyelination in regions with increased oligodendroglial cell densities, regardless of the harbouring of SLC35A2 variants. Notably, this hypomyelination pattern decreased with age. These results suggested a role for the SLC35A2 protein in the pathogenesis of MOGHE and indicated the presence of additional myelin-associated pathomechanisms in those individuals who do not carry a pathogenic SLC35A2 variant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuropathology, Partner of the European Reference Network (ERN) EpiCARE, Universitätsklinikum Erlangen, Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.
- Institute of Functional and Clinical Anatomy, FAU Erlangen-Nürnberg, Erlangen, Germany.
- Department of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.
- Center for Pediatric Neurology, Neurorehabilitation, and Epileptology, Schoen-Clinic, Vogtareuth, Germany.
- Research Institute for Rehabilitation, Transition, and Palliation, Paracelsus Medical University, Salzburg, Austria.
- Department of Epileptology, Krankenhaus Mara, Bethel Epilepsy Center, Medical School OWL, Bielefeld University, Bielefeld, Germany.
ORCID-Profile: Erica Cecchini, Roland Coras, Kristina Karandasheva, Friedrich Paulsen, Christine Stadelmann, Katja Kobow, Till Hartlieb, Christian G Bien, Dennis Lal, Ingmar Blumcke, Lucas Hoffmann
Förderung
- NINDS NIH HHS
- Deutsche Forschungsgemeinschaft
- Universitätsklinikum Erlangen
Zitieren
APA
Cecchini, E., Geffers, S., Coras, R., Schultheis, D., Holtzhausen, C., Karandasheva, K., Herrmann, H., Paulsen, F., Stadelmann, C., Kobow, K., Hartlieb, T., Bien, C. G., Lal, D., Blumcke, I., & Hoffmann, L. (2025). Human brain tissue with MOGHE carrying somatic SLC35A2 variants reveal aberrant protein expression and protein loss in the white matter. Acta Neuropathologica, 149(1). https://doi.org/10.1007/s00401-025-02858-7
Vancouver
Cecchini E, Geffers S, Coras R, Schultheis D, Holtzhausen C, Karandasheva K, et al. Human brain tissue with MOGHE carrying somatic SLC35A2 variants reveal aberrant protein expression and protein loss in the white matter. Acta Neuropathologica. 2025;149(1). doi:10.1007/s00401-025-02858-7
BibTeX
@article{Cecchini2025,
author = {Cecchini, Erica and Geffers, Simon and Coras, Roland and Schultheis, Dorothea and Holtzhausen, Christian and Karandasheva, Kristina and Herrmann, Harald and Paulsen, Friedrich and Stadelmann, Christine and Kobow, Katja and Hartlieb, Till and Bien, Christian G and Lal, Dennis and Blumcke, Ingmar and Hoffmann, Lucas},
title = {Human brain tissue with MOGHE carrying somatic SLC35A2 variants reveal aberrant protein expression and protein loss in the white matter},
journal = {Acta Neuropathologica},
year = {2025},
volume = {149},
number = {1},
doi = {10.1007/s00401-025-02858-7}
}
EUVIMED